MAIA Biotechnology, Inc.

US$1.06As of Sun 8 Nov 2026, 12:00 UTC
AMEX:MAIAHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (32.81%)
Div yield —
ROE (218.68%)
Biotechnology
Beta (5Y) 0.30
PE TTM —
TSR TTM (14.52%)
Mkt cap US$64.48M
ROIC (147.37%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.03
(3.17%)
22.14%
Hold 0|7|3|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
11.00%
7.37%
15.83%
4.06%
Revenue$M
8.673
8.777
8.727
8.574
9.13%
10.52%
4.79%
(1.40%)
Peers (US$64.48M)
Cap (US$)
PE
64.32M
—
Capital
TTM
5Y
10Y
Leveragex
0.278
(0.595)
(0.561)
EBIT/Intx
0.337
0.430
0.398
Own earn%
(61.44)
(148.32)
(123.09)
Sh yield%
45.78
28.78
28.43
Owners
Insiders/Inst%
11.54
55.16
Short interest%
1.11
SBC / revenue%
3.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
22–25
$1 testx
—
Incr. ROIC%
7